
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated robust organic revenue growth, with impressive Year-over-Year (y/y) figures of +12.3% in 2023, +7.7% in 2024, and +7.4% in 2025 year-to-date, indicating a strong recovery and ongoing demand in its Personal Care segment. The recent +2.6% Medicare Hospice rate increase, effective October 1, 2025, further enhances the company's revenue potential within its Hospice segment, which is projected to achieve revenue growth of +5% to +7%. Additionally, strategic opportunities for mergers and acquisitions, along with operational enhancements from leadership changes within the Hospice division, are expected to provide significant near-term upside for the company.
Bears say
Addus HomeCare has experienced same-store declines in 2025 year-to-date results, primarily due to the effects of Medicaid redeterminations, which have led to administrative challenges in onboarding new patients and increased discharges relative to new admissions. Approximately 97% of its segment revenues are vulnerable to uncertainty regarding future Medicaid funding, further complicating the financial outlook as influenced by the One Big Beautiful Bill Act (OBBBA). Although the company maintains a favorable long-term demand backdrop and has executed steadily, its equity performance has lagged behind the broader post-acute care sector, indicating a disconnect between equity valuation and underlying fundamentals.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares